CoChat

Efficacy and Safety of Nebivolol in Elderly Heart Failure Patients with Impaired Renal Function: Insights from the SENIORS Trial

Open access
Cohen-Solal, Alain, Kotecha, Dipak, van Veldhuisen, Dirk J, Babalis, Daphne, Böhm, Michael, Coats, Andrew J., Roughton, Michael, Poole-Wilson, Philip, Tavazzi, Luigi, Flather, Marcus · 2009 · European Journal of Heart Failure
Cited by 100

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aim: To determine the safety and efficacy of nebivolol in elderly heart failure (HF) patients with renal dysfunction. Methods and results: SENIORS recruited patients aged 70 years or older with symptomatic HF, irrespective of ejection fraction, and randomized them to nebivolol or placebo. Patients (n = 2112) were divided by tertile of estimated glomerular filtration rate (eGFR). Mean age of patients was 76.1 years, 35% of patients had an ejection fraction of >35%, and 37% were women resulting in a unique cohort, far more representative of clinical practice than previous trials. eGFR was strongly associated with outcomes and nebivolol was similarly efficacious across eGFR tertiles. The primary outcome rate (all-cause mortality or cardiovascular hospital admission) and adjusted hazard ratio for nebivolol use in those with low eGFR was 40% and 0.84 (95% CI 0.67–1.07), 31% and 0.79 (0.60–1.04) in the middle tertile, and 29% and 0.86 (0.65–1.14) in the highest eGFR tertile. There was no interaction noted between renal function and the treatment effect (P = 0.442). Nebivolol use in patients with moderate renal impairment (eGFR <60) was not associated with major safety concerns, apart from higher rates of drug-discontinuation due to bradycardia. Conclusion: Nebivolol is safe and has a similar effect in elderly HF patients with mild or moderate renal impairment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfp104

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 100

Metadata

Authors
Cohen-Solal, A., Kotecha, D., van Veldhuisen, D. J., Babalis, D., Böhm, M., Coats, A. J., Roughton, M., Poole-Wilson, P., Tavazzi, L., & Flather, M.
Venue
European Journal of Heart Failure
Published
2009-08-20
Volume
11
Issue
9
Pages
872-880
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W1991662102
Cited by
100
References
3
FWCI
4.55
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Safety of Nebivolol in Elderly Heart Failure Patients with Impaired Renal Function: Insights from the SENIORS Trial. https://app.cochat.ai/papers/10.1093/eurjhf/hfp104
The paper
Cohen-Solal, A., Kotecha, D., van Veldhuisen, D. J., Babalis, D., Böhm, M., Coats, A. J., Roughton, M., Poole-Wilson, P., Tavazzi, L., & Flather, M. (2009). Efficacy and Safety of Nebivolol in Elderly Heart Failure Patients with Impaired Renal Function: Insights from the SENIORS Trial. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfp104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.